IRF4 in multiple myeloma—Biology, disease and therapeutic target
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference96 articles.
1. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol.,2014
2. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management;Rajkumar;Am. J. Hematol.,2016
3. A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival;Botta;Blood Cancer J.,2016
4. Multiple myeloma: diagnosis and treatment;Rajkumar;Mayo Clin. Proc.,2016
5. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study;Kumar;Leukemia,2017
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IRF4 mediates non-enzymatic dependency on IRE1 in Multiple Myeloma cells;2024-08-01
2. C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma;Blood Advances;2024-04-29
3. Assessing Interferon Regulatory Factor 4 Complex Formation: Differential Behavior of Homocomplexes Versus Heterocomplexes Induced by Mutations;Biochemistry;2024-03-05
4. Genetic landscape and prognostic value of IRF4 alterations in Diffuse large B-cell lymphoma patients;2024-02-07
5. IRF4 induces M1 macrophage polarization and aggravates ulcerative colitis progression by the Bcl6‐dependent STAT3 pathway;Environmental Toxicology;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3